Profil
Emma Beausang is currently working as the VP-Regulatory Affairs & Quality Assurance at GH Research Plc.
Previously, she worked as the Vice President-Regulatory Affairs at Aerie Pharmaceuticals, Inc. Dr. Beausang holds a doctorate degree from UCL School of Pharmacy and an undergraduate degree from the University of Strathclyde.
Aktive Positionen von Emma Beausang
| Unternehmen | Position | Beginn |
|---|---|---|
| GH RESEARCH PLC | General Counsel | - |
Ehemalige bekannte Positionen von Emma Beausang
| Unternehmen | Position | Ende |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | General Counsel | 01.12.2021 |
Ausbildung von Emma Beausang
| University of Strathclyde | Undergraduate Degree |
| UCL School of Pharmacy | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
